Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Case Rep ; 9(3): 1571-1576, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33768891

RESUMEN

A comprehensive work-up, clinical correlation, and differential diagnosis are needed to determine if abnormal findings such us hydromyelia in ALS patients are causative or incidental in order to rule out other, more curable conditions that resemble ALS.

2.
J Laryngol Otol ; 133(2): 110-114, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30706841

RESUMEN

OBJECTIVE: Adenotonsillectomy is frequently performed for obstructive sleep apnoea, but is associated with post-operative respiratory morbidity. This study assessed the effect of paediatric Otrivine (0.05 per cent xylometazoline hydrochloride) on post-operative respiratory compromise. METHODS: Paediatric patients undergoing adenotonsillectomy for obstructive sleep apnoea were included. The control group (n = 24) received no intervention and the intervention group (n = 25) received intra-operative paediatric Otrivine during induction using a nasal patty. Post-operative outcomes included pain, respiratory distress signs and medical intervention level required (simple, intermediate and major). RESULTS: Post-operative respiratory distress signs were exhibited by 4 per cent of the Otrivine group and 21 per cent of the control group. Sixty-eight per cent of the Otrivine group required simple medical interventions post-operatively, compared to 42 per cent of the control group. In the Otrivine group, 4 per cent required intermediate interventions; none required major interventions. In the control group, 12.5 per cent required both intermediate and major interventions. Fifty per cent of the control group reported pain post-operatively, compared with 40 per cent in the Otrivine group. CONCLUSION: Intra-operative paediatric Otrivine may reduce post-operative respiratory compromise in paediatric patients undergoing adenotonsillectomy for obstructive sleep apnoea. A randomised controlled trial is required.


Asunto(s)
Adenoidectomía/efectos adversos , Descongestionantes Nasales/administración & dosificación , Cuidados Posoperatorios/métodos , Complicaciones Posoperatorias , Apnea Obstructiva del Sueño/tratamiento farmacológico , Tonsilectomía/efectos adversos , Preescolar , Femenino , Humanos , Lactante , Masculino , Proyectos Piloto , Polisomnografía , Apnea Obstructiva del Sueño/etiología , Apnea Obstructiva del Sueño/fisiopatología
3.
Clin Otolaryngol ; 43(5): 1201-1208, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-29706016

RESUMEN

OBJECTIVE: The aim of the study was to perform a systematic review of existing evidence on the role of local anaesthetic nerve block (LAB) in patients undergoing endoscopic sinus surgery (ESS). DESIGN: The databases searched were the Cochrane Register of Controlled Trials, MEDLINE and Embase using the Ovid portal (1946-2017). RESULTS: Seven randomised controlled trials were included. Due to considerable heterogeneity of data, only two studies were pooled into meta-analysis which demonstrated a statistically significantly better surgical field quality during ESS in the LAB group compared with the control group (MD -0.86; 95% CI -2.24, 0.51; P = .009). No adverse events related to LAB toxicity were reported. CONCLUSIONS: Sphenopalatine ganglion LAB with adrenaline carries relatively low risk of morbidity, but may improve the quality of the surgical field in terms of bleeding. However, there are limitations of the study due to heterogeneity of methods, quality and size of the studies. Well-conducted large RCTs are needed using standardised inclusion criteria, balanced baseline characteristics of cohorts, and validated subjective and objective outcome measures.


Asunto(s)
Anestésicos Locales/uso terapéutico , Endoscopía , Bloqueo Nervioso , Rinitis/cirugía , Sinusitis/cirugía , Humanos
4.
Eur J Cancer ; 50(10): 1697-1705, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24768572

RESUMEN

INTRODUCTION: Predictors for site of distant metastasis and impact on survival in breast cancer are incompletely understood. METHODS: Clinico-pathological risk factors for site of distant metastasis and survival were analysed in patients with invasive breast cancer treated between 1986 and 2006. RESULTS: Of 3553 patients, with median follow-up 6.32years, 825 (23%) developed distant metastasis. The site of metastasis was bone in 196/825 (24%), viscera in 540/825 (65%) and unknown in 89 (11%). Larger primary invasive tumour size, higher tumour grade and axillary nodal positivity increased risk of metastasis to all sites. Lobular carcinoma was more likely to first metastasise to bone compared to invasive ductal carcinoma (NST). Oestrogen receptor (ER) negative, progesterone receptor (PgR) negative and/or Human epidermal growth factor (HER2) positive tumours were more likely to metastasise to viscera. A striking relationship between increasing age at diagnosis and a reduction in risk of distant metastasis to bone and viscera was observed. Median time to death from onset of metastatic disease was 1.52 (Interquartile range (IQR) 0.7-2.9)years for patients with bone metastasis and 0.7 (IQR 0.2-1.5)years for visceral metastasis. On multivariate analysis, despite the decrease in risk of distant metastasis with increasing age, there was an elevated hazard for death in patients >50years at diagnosis of metastasis if they developed bone metastasis, with a similar trend observed in the >70years age group if they developed visceral metastasis. CONCLUSION: These findings indicate that there are biological mechanisms underlying the impact of age on the development of distant metastasis and subsequent death. This may have important implications in the treatment of breast cancer.


Asunto(s)
Neoplasias Óseas/secundario , Neoplasias de la Mama/patología , Carcinoma Ductal de Mama/secundario , Carcinoma Lobular/secundario , Adulto , Factores de Edad , Anciano , Biomarcadores de Tumor/análisis , Neoplasias Óseas/química , Neoplasias Óseas/mortalidad , Neoplasias Óseas/terapia , Neoplasias de la Mama/química , Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/terapia , Carcinoma Ductal de Mama/química , Carcinoma Ductal de Mama/mortalidad , Carcinoma Ductal de Mama/terapia , Carcinoma Lobular/química , Carcinoma Lobular/mortalidad , Carcinoma Lobular/terapia , Supervivencia sin Enfermedad , Receptores ErbB/análisis , Femenino , Humanos , Metástasis Linfática , Persona de Mediana Edad , Análisis Multivariante , Clasificación del Tumor , Invasividad Neoplásica , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Receptores de Estrógenos/análisis , Receptores de Progesterona/análisis , Sistema de Registros , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento , Carga Tumoral
5.
J Laryngol Otol ; 127(2): 200-2, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23253569

RESUMEN

OBJECTIVE: To outline the management options and neurological complications associated with repeated traumatic falls that cause intrusion of bone-anchored hearing aid abutments. CASE REPORT: A three-year-old boy with coloboma, heart defects, atresia of nasal choanae, retarded growth, genital abnormalities, ear defects and deafness was fitted with a bone-anchored hearing aid for severe conductive hearing loss and congenital ear malformations. Six months later, a traumatic fall caused an intrusion injury which rendered the bone-anchored hearing aid abutment unusable. Without removing the original abutment, a second abutment was inserted on the same side to aid his hearing. Two years later, the child fell again and damaged his second bone-anchored hearing aid abutment. Having been offered a surgical option to repair the area, the parents opted to keep the abutments in situ. CONCLUSION: Direct trauma to the fixture of a bone-anchored hearing aid is a relatively common long-term complication in children which can disrupt osseointegration and disable the implant. For young children who are either prone to falling or have behavioural problems, a bone-anchored hearing aid Softband may be more appropriate to non-invasively aid hearing.


Asunto(s)
Accidentes por Caídas , Audífonos , Pérdida Auditiva Conductiva/rehabilitación , Implantación de Prótesis/métodos , Fracturas Craneales/etiología , Hueso Temporal/lesiones , Preescolar , Pérdida Auditiva Conductiva/cirugía , Humanos , Masculino , Oseointegración , Resultado del Tratamiento
6.
Integr Biol (Camb) ; 3(6): 603-31, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21541433

RESUMEN

We review novel, in vivo and tissue-based imaging technologies that monitor and optimize cancer therapeutics. Recent advances in cancer treatment centre around the development of targeted therapies and personalisation of treatment regimes to individual tumour characteristics. However, clinical outcomes have not improved as expected. Further development of the use of molecular imaging to predict or assess treatment response must address spatial heterogeneity of cancer within the body. A combination of different imaging modalities should be used to relate the effect of the drug to dosing regimen or effective drug concentration at the local site of action. Molecular imaging provides a functional and dynamic read-out of cancer therapeutics, from nanometre to whole body scale. At the whole body scale, an increase in the sensitivity and specificity of the imaging probe is required to localise (micro)metastatic foci and/or residual disease that are currently below the limit of detection. The use of image-guided endoscopic biopsy can produce tumour cells or tissues for nanoscopic analysis in a relatively patient-compliant manner, thereby linking clinical imaging to a more precise assessment of molecular mechanisms. This multimodality imaging approach (in combination with genetics/genomic information) could be used to bridge the gap between our knowledge of mechanisms underlying the processes of metastasis, tumour dormancy and routine clinical practice. Treatment regimes could therefore be individually tailored both at diagnosis and throughout treatment, through monitoring of drug pharmacodynamics providing an early read-out of response or resistance.


Asunto(s)
Biomarcadores de Tumor/análisis , Imagen Molecular/métodos , Proteínas de Neoplasias/análisis , Neoplasias/diagnóstico , Neoplasias/terapia , Humanos , Neoplasias/metabolismo , Integración de Sistemas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA